Financhill
Sell
26

LUCY Quote, Financials, Valuation and Earnings

Last price:
$1.50
Seasonality move :
13.8%
Day range:
$1.37 - $1.50
52-week range:
$1.29 - $7.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.00x
P/B ratio:
0.77x
Volume:
171.5K
Avg. volume:
768.9K
1-year change:
-80.14%
Market cap:
$7.9M
Revenue:
$1.6M
EPS (TTM):
-$2.62

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
LUCY
Innovative Eyewear, Inc.
$1M -$0.49 73.74% -50.4% $3.00
COO
The Cooper Cos., Inc.
$1.1B $1.11 6.03% 93.61% $82.25
KIDS
OrthoPediatrics Corp.
$62M -$0.26 12.55% -53.5% $24.14
NXGL
NexGel, Inc.
$3.2M -$0.08 6.54% -22.68% $6.00
PAHC
Phibro Animal Health Corp.
$345.4M $0.60 15% 756.68% $43.00
STAA
STAAR Surgical Co.
$89.4M $0.28 57.14% 39.51% $25.88
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
LUCY
Innovative Eyewear, Inc.
$1.47 $3.00 $7.9M -- $0.00 0% 2.00x
COO
The Cooper Cos., Inc.
$77.03 $82.25 $15.3B 37.92x $0.01 0% 3.82x
KIDS
OrthoPediatrics Corp.
$18.17 $24.14 $455.7M -- $0.00 0% 1.87x
NXGL
NexGel, Inc.
$1.64 $6.00 $13.4M -- $0.00 0% 1.07x
PAHC
Phibro Animal Health Corp.
$40.77 $43.00 $1.7B 24.51x $0.12 1.18% 1.19x
STAA
STAAR Surgical Co.
$26.37 $25.88 $1.3B 49.73x $0.00 0% 5.68x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
LUCY
Innovative Eyewear, Inc.
1.01% 5.608 1.04% 9.17x
COO
The Cooper Cos., Inc.
22.88% 0.349 17.63% 0.96x
KIDS
OrthoPediatrics Corp.
22.39% -0.034 21.68% 3.39x
NXGL
NexGel, Inc.
38.1% -0.508 15.76% 0.82x
PAHC
Phibro Animal Health Corp.
71.58% 2.736 47.87% 1.12x
STAA
STAAR Surgical Co.
9.96% 0.980 2.95% 4.10x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
LUCY
Innovative Eyewear, Inc.
$244.8K -$1.9M -79.57% -80% -287.5% -$1.5M
COO
The Cooper Cos., Inc.
$642M $175.7M 3.79% 5% 16.57% $164.5M
KIDS
OrthoPediatrics Corp.
$40M -$4.9M -10.3% -12.83% -7.95% -$3.4M
NXGL
NexGel, Inc.
$1.2M -$725K -33.25% -51.15% -24.71% -$793K
PAHC
Phibro Animal Health Corp.
$119.3M $47.9M 6.8% 24.77% 13.16% -$4.5M
STAA
STAAR Surgical Co.
$76.6M $44.5M -23.38% -25.83% 46.96% $1.8M

Innovative Eyewear, Inc. vs. Competitors

  • Which has Higher Returns LUCY or COO?

    The Cooper Cos., Inc. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of 9.27%. Innovative Eyewear, Inc.'s return on equity of -80% beat The Cooper Cos., Inc.'s return on equity of 5%.

    Company Gross Margin Earnings Per Share Invested Capital
    LUCY
    Innovative Eyewear, Inc.
    36.64% -$0.38 $10.4M
    COO
    The Cooper Cos., Inc.
    60.55% $0.49 $10.8B
  • What do Analysts Say About LUCY or COO?

    Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 104.08%. On the other hand The Cooper Cos., Inc. has an analysts' consensus of $82.25 which suggests that it could grow by 6.78%. Given that Innovative Eyewear, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Innovative Eyewear, Inc. is more attractive than The Cooper Cos., Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    LUCY
    Innovative Eyewear, Inc.
    0 0 0
    COO
    The Cooper Cos., Inc.
    6 6 1
  • Is LUCY or COO More Risky?

    Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Cooper Cos., Inc. has a beta of 1.048, suggesting its more volatile than the S&P 500 by 4.779%.

  • Which is a Better Dividend Stock LUCY or COO?

    Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cooper Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. The Cooper Cos., Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LUCY or COO?

    Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than The Cooper Cos., Inc. quarterly revenues of $1.1B. Innovative Eyewear, Inc.'s net income of -$1.8M is lower than The Cooper Cos., Inc.'s net income of $98.3M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while The Cooper Cos., Inc.'s PE ratio is 37.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 2.00x versus 3.82x for The Cooper Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LUCY
    Innovative Eyewear, Inc.
    2.00x -- $668.1K -$1.8M
    COO
    The Cooper Cos., Inc.
    3.82x 37.92x $1.1B $98.3M
  • Which has Higher Returns LUCY or KIDS?

    OrthoPediatrics Corp. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of -19.22%. Innovative Eyewear, Inc.'s return on equity of -80% beat OrthoPediatrics Corp.'s return on equity of -12.83%.

    Company Gross Margin Earnings Per Share Invested Capital
    LUCY
    Innovative Eyewear, Inc.
    36.64% -$0.38 $10.4M
    KIDS
    OrthoPediatrics Corp.
    65.27% -$0.50 $450.1M
  • What do Analysts Say About LUCY or KIDS?

    Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 104.08%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.14 which suggests that it could grow by 32.87%. Given that Innovative Eyewear, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe Innovative Eyewear, Inc. is more attractive than OrthoPediatrics Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    LUCY
    Innovative Eyewear, Inc.
    0 0 0
    KIDS
    OrthoPediatrics Corp.
    3 1 0
  • Is LUCY or KIDS More Risky?

    Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.186%.

  • Which is a Better Dividend Stock LUCY or KIDS?

    Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LUCY or KIDS?

    Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than OrthoPediatrics Corp. quarterly revenues of $61.3M. Innovative Eyewear, Inc.'s net income of -$1.8M is higher than OrthoPediatrics Corp.'s net income of -$11.8M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 2.00x versus 1.87x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LUCY
    Innovative Eyewear, Inc.
    2.00x -- $668.1K -$1.8M
    KIDS
    OrthoPediatrics Corp.
    1.87x -- $61.3M -$11.8M
  • Which has Higher Returns LUCY or NXGL?

    NexGel, Inc. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of -22.05%. Innovative Eyewear, Inc.'s return on equity of -80% beat NexGel, Inc.'s return on equity of -51.15%.

    Company Gross Margin Earnings Per Share Invested Capital
    LUCY
    Innovative Eyewear, Inc.
    36.64% -$0.38 $10.4M
    NXGL
    NexGel, Inc.
    40.93% -$0.08 $8.8M
  • What do Analysts Say About LUCY or NXGL?

    Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 104.08%. On the other hand NexGel, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 265.85%. Given that NexGel, Inc. has higher upside potential than Innovative Eyewear, Inc., analysts believe NexGel, Inc. is more attractive than Innovative Eyewear, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    LUCY
    Innovative Eyewear, Inc.
    0 0 0
    NXGL
    NexGel, Inc.
    0 0 0
  • Is LUCY or NXGL More Risky?

    Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock LUCY or NXGL?

    Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LUCY or NXGL?

    Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than NexGel, Inc. quarterly revenues of $2.9M. Innovative Eyewear, Inc.'s net income of -$1.8M is lower than NexGel, Inc.'s net income of -$647K. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 2.00x versus 1.07x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LUCY
    Innovative Eyewear, Inc.
    2.00x -- $668.1K -$1.8M
    NXGL
    NexGel, Inc.
    1.07x -- $2.9M -$647K
  • Which has Higher Returns LUCY or PAHC?

    Phibro Animal Health Corp. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of 7.29%. Innovative Eyewear, Inc.'s return on equity of -80% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    LUCY
    Innovative Eyewear, Inc.
    36.64% -$0.38 $10.4M
    PAHC
    Phibro Animal Health Corp.
    32.8% $0.65 $1.1B
  • What do Analysts Say About LUCY or PAHC?

    Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 104.08%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 5.47%. Given that Innovative Eyewear, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe Innovative Eyewear, Inc. is more attractive than Phibro Animal Health Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    LUCY
    Innovative Eyewear, Inc.
    0 0 0
    PAHC
    Phibro Animal Health Corp.
    0 2 0
  • Is LUCY or PAHC More Risky?

    Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

  • Which is a Better Dividend Stock LUCY or PAHC?

    Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.18% to investors and pays a quarterly dividend of $0.12 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios LUCY or PAHC?

    Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. Innovative Eyewear, Inc.'s net income of -$1.8M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 2.00x versus 1.19x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LUCY
    Innovative Eyewear, Inc.
    2.00x -- $668.1K -$1.8M
    PAHC
    Phibro Animal Health Corp.
    1.19x 24.51x $363.9M $26.5M
  • Which has Higher Returns LUCY or STAA?

    STAAR Surgical Co. has a net margin of -274.85% compared to Innovative Eyewear, Inc.'s net margin of 9.38%. Innovative Eyewear, Inc.'s return on equity of -80% beat STAAR Surgical Co.'s return on equity of -25.83%.

    Company Gross Margin Earnings Per Share Invested Capital
    LUCY
    Innovative Eyewear, Inc.
    36.64% -$0.38 $10.4M
    STAA
    STAAR Surgical Co.
    80.89% $0.18 $392.9M
  • What do Analysts Say About LUCY or STAA?

    Innovative Eyewear, Inc. has a consensus price target of $3.00, signalling upside risk potential of 104.08%. On the other hand STAAR Surgical Co. has an analysts' consensus of $25.88 which suggests that it could fall by -1.88%. Given that Innovative Eyewear, Inc. has higher upside potential than STAAR Surgical Co., analysts believe Innovative Eyewear, Inc. is more attractive than STAAR Surgical Co..

    Company Buy Ratings Hold Ratings Sell Ratings
    LUCY
    Innovative Eyewear, Inc.
    0 0 0
    STAA
    STAAR Surgical Co.
    1 10 0
  • Is LUCY or STAA More Risky?

    Innovative Eyewear, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.806%.

  • Which is a Better Dividend Stock LUCY or STAA?

    Innovative Eyewear, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Innovative Eyewear, Inc. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LUCY or STAA?

    Innovative Eyewear, Inc. quarterly revenues are $668.1K, which are smaller than STAAR Surgical Co. quarterly revenues of $94.7M. Innovative Eyewear, Inc.'s net income of -$1.8M is lower than STAAR Surgical Co.'s net income of $8.9M. Notably, Innovative Eyewear, Inc.'s price-to-earnings ratio is -- while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Innovative Eyewear, Inc. is 2.00x versus 5.68x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LUCY
    Innovative Eyewear, Inc.
    2.00x -- $668.1K -$1.8M
    STAA
    STAAR Surgical Co.
    5.68x 49.73x $94.7M $8.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
44
PSTG alert for Dec 5

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.

Buy
69
ASTS alert for Dec 5

AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock